Oral Oncology
Volume 37, Issue 7 , Pages 599-604 , October 2001

Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions

Received 11 December 2000 ,Revised 8 February 2001 ,Accepted 22 April 2001.

References 

  1. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. Tokyo: Springer; 1997;
  2. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol. 1995;79(3):321–329
  3. Cohen S, Carpenter G, King L. Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem. 1980;255(10):4834–4842
  4. Carter TH, Kung HJ. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit Rev Oncog. 1994;5(4):389–428
  5. Ishitoya J, Toriyama M, Oguchi N, Kitamura K, Ohshima M, Asano K, et al.  Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer. 1989;59(4):559–562
  6. Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK. Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer. 1991;48(4):511–515
  7. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi VD, Deo MG. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Eur J Cancer B Oral Oncol. 1992;28B(2):139–143
  8. Rodrigo JP, Ramos S, Lazo PS, Alvarez I, Suarez C. Amplification of erbB oncogenes in squamous cell carcinomas of the head and neck. Eur J Cancer. 1996;32A(11):2004–2010
  9. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, et al.  Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer. 1994;74(3):795–804
  10. Kitagawa Y, Ueda M, Ando N, Ozawa S, Shimizu N, Kitajima M. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 1996;2(5):909–914
  11. Gorgoulis V, Sfikakis PP, Karameris A, Papastamatiou H, Trigidou R, Veslimes M, et al.  Molecular and immunohistochemical study of class I growth factor receptors in squamous cell lung carcinomas. Path Res Pract. 1995;191:973–981
  12. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol. 1992;51(1):84–90
  13. Werkmeister R, Brandt B, Joos U. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity. Br J Oral Maxillofac Surg. 1999;37(6):477–480
  14. Frye RA, Benz CC, Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene. 1989;4(9):1153–1157
  15. Diviacco S, Norio P, Zentilin L, Menzo S, Clementi M, Biamonti G, et al.  A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene. 1992;122(2):313–320
  16. Celi FS, Cohen MM, Antonarakis SE, Wertheimer E, Roth J, Shuldiner AR. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences. Genomics. 1994;21(2):304–310
  17. Lönn U, Lönn S, Nylén U, Friberg S, Stenkvist B. Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method. Cancer. 1993;71(11):3605–3610
  18. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. New York: Cold Spring Harbor Laboratory Press; 1989;
  19. Mao EJ, Schwartz SM, Daling JR, Oda D, Tickman L, Beckmann AM. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer. 1996;69(2):152–158
  20. Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, et al.  High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene. 1997;15(22):2667–2674
  21. Rowley H, Sherrington P, Helliwell TR, Kinsella A, Jones AS. p53 expression and p53 gene mutation in oral cancer and dysplasia. Otolaryngol Head Neck Surg. 1998;118(1):15–23
  22. Papadimitrakopoulou V, Izzo J, Lippman SM, Lee JS, Fan YH, Clayman G, et al.  Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene. 1997;14(15):1799–1803
  23. Lee JS, Kim SY, Hong WK, Lippman SM, Ro JY, Gay ML, et al.  Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst. 1993;85(23):1951–1954
  24. Shackney SE, Shankey TV. Common patterns of genetic evolution in human solid tumors. Cytometry. 1997;29(1):1–27
  25. Persons DL, Croughan WS, Borelli KA, Cherian R. Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. Cancer Genet Cytogenet. 1998;106(1):11–17

PII: S1368-8375(01)00051-3

Oral Oncology
Volume 37, Issue 7 , Pages 599-604 , October 2001